1-4 of 4
Rosa Fonti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non–Small Cell Lung Cancer Detected by 18F-fluorothymidine

Francesca Iommelli, Viviana De Rosa, Cristina Terlizzi, Marcello Monti, Mariarosaria Panico, Rosa Fonti, Silvana Del Vecchio
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (13): 3126–3136.
https://doi.org/10.1158/1078-0432.CCR-17-3657
Published: 01 July 2018
View article titled, Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non–Small Cell Lung Cancer Detected by <sup>18</sup>F-fluorothymidine
Open the PDF for Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non–Small Cell Lung Cancer Detected by <sup>18</sup>F-fluorothymidine in another window
Includes: Supplementary data
Journal Articles

Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non–Small Cell Lung Cancer

Viviana De Rosa, Francesca Iommelli, Marcello Monti, Rosa Fonti, Giuseppina Votta, Maria Patrizia Stoppelli, Silvana Del Vecchio
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (22): 5110–5120.
https://doi.org/10.1158/1078-0432.CCR-15-0375
Published: 12 November 2015
View article titled, Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non–Small Cell Lung Cancer
Open the PDF for Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non–Small Cell Lung Cancer in another window
Journal Articles

Monitoring Reversal of MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer Using 3′-Deoxy-3′-[18F]-Fluorothymidine Positron Emission Tomography

Francesca Iommelli, Viviana De Rosa, Sara Gargiulo, Mariarosaria Panico, Marcello Monti, Adelaide Greco, Matteo Gramanzini, Giovanni Ortosecco, Rosa Fonti, Arturo Brunetti, Silvana Del Vecchio
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (18): 4806–4815.
https://doi.org/10.1158/1078-0432.CCR-14-0264
Published: 14 September 2014
View article titled, Monitoring Reversal of MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer Using 3′-Deoxy-3′-[<sup>18</sup>F]-Fluorothymidine Positron Emission Tomography
Open the PDF for Monitoring Reversal of MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer Using 3′-Deoxy-3′-[<sup>18</sup>F]-Fluorothymidine Positron Emission Tomography in another window
Journal Articles

Gefitinib Induction of In vivo Detectable Signals by Bcl-2/Bcl-xL Modulation of Inositol Trisphosphate Receptor Type 3

Antonella Zannetti, Francesca Iommelli, Rosa Fonti, Angela Papaccioli, Jvana Sommella, Anna Lettieri, Giuseppe Pirozzi, Roberto Bianco, Giampaolo Tortora, Marco Salvatore, Silvana Del Vecchio
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (16): 5209–5219.
https://doi.org/10.1158/1078-0432.CCR-08-0374
Published: 12 August 2008
View article titled, Gefitinib Induction of <em>In vivo</em> Detectable Signals by Bcl-2/Bcl-x<sub>L</sub> Modulation of Inositol Trisphosphate Receptor Type 3
Open the PDF for Gefitinib Induction of <em>In vivo</em> Detectable Signals by Bcl-2/Bcl-x<sub>L</sub> Modulation of Inositol Trisphosphate Receptor Type 3 in another window